Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
|Articles|October 2, 2015
- Pharmaceutical Technology-10-02-2015
- Volume 38
- Issue 10
Control Systems
Ross SysCon’s UL-rated and CE-marked control systems are custom-designed for industrial processes such as mixing, pumping, chemical dosing, dilution, heat exchange, separation, drying, and waste treatment.
Ross SysCon’s UL-rated and CE-marked control systems are custom-designed for industrial processes such as mixing, pumping, chemical dosing, dilution, heat exchange, separation, drying, and waste treatment. These PLC-based controls are routinely supplied with a recipe-sequencing program, calibration menus, trending screens, data acquisition (SCADA) packages, operator-friendly alarms, and advanced safety features. Process variables are controlled and displayed from a responsive color touchscreen and can be automatically stored for seamless monitoring and reporting.
The control systems are UL (Underwriters Laboratories)-rated and built to conform to NFPA (National Fire Protection Association) 79 standards. CE marking can be provided as well to indicate full compliance with EU requirements. Enclosures and cabinets are NEMA (National Electrical Manufacturers Association) 12 for non-hazardous environments, NEMA 7&9 for explosion-proof requirements, or NEMA 4X (stainless steel) for washdown applications.
Ross, Charles & Son
Articles in this issue
almost 11 years ago
Identifying Powder Properties that Define Process Performancealmost 11 years ago
Connecting MES to Process Controlalmost 11 years ago
Parenteral Packaging Advancesalmost 11 years ago
Serialization Shake Outalmost 11 years ago
Investigating Biologicsalmost 11 years ago
Advances in Fluorination Chemistry for API Synthesisalmost 11 years ago
Small-Molecule API CMOs Are Thrivingalmost 11 years ago
Modular Platform for Agitator Bead Mill Optimizes Grindingalmost 11 years ago
Self-Contained Laboratory Homogenizer Prepares Injectable DrugsRelated to this article
This article discusses risk-based lifecycle governance, system implementation considerations, and the progression of batch record control from paper-based to fully electronic systems.
Ronald Piervincenzi, USP, explains why manufacturers should act now and how benchmarking could reward reliable generic drug suppliers.
The FDA approves Lilly's once-weekly insulin efsitora for type 2 diabetes, raising Fc-fusion manufacturing, high-concentration pen, and capacity questions.
Florin Muraru, Gourav Pandey, and Richard Jaenisch explain where human sign-off belongs as multi-agent AI and document-parsing models reach GxP.
In this episode of Ask the Expert, Siegfried Schmitt, PhD, vice president, Technical at Parexel, and Susan J. Schniepp, distinguished fellow at Nelson Labs, discuss how companies should approach post-approval changes to their CMC regulatory filings.
The EC has approved AstraZeneca's Trixeo Aerosphere as the first single-inhaler triple-combination therapy for asthma in the EU, based on phase e data showing improved lung function and fewer severe exacerbations in patients uncontrolled on standard ICS/LABA treatment.
In this episode of Pharma Fundamentals, Dr. Aleksandra Zuraw, senior veterinary pathologist at Charles River, provides an introduction to the use of digital pathology in drug development.
Trending on Pharmaceutical Technology
1
Risk-Based Life Cycle Management of Master Production and Control Records to Strengthen Data Integrity and GMP Inspection Readiness Part 2: Practical Considerations for CGMP Documentation Systems
2
PharmTech’s Weekly Roundup—September 25, 2026
3
The FDA Finalizes Rule Recognizing Non-Animal Testing Methods, Building on Year-Long Reduction Push
4
CPHI Milan: USP Benchmarks Reshape Procurement Incentives
5